Danazol: in vitro effects on human hemopoiesis and in vivo activity in hypoplastic and myelodysplastic disorders
article
OA: closed
CC0
⤵ 5 in-corpus citations
AI-generated summary
Danazol stimulated CFU-GM colony growth in vitro and showed hematologic response in vivo in hypoplastic disorders but not in myelodysplastic disorders.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
We examined the effects of danazol on in vitro growth of human bone marrow and peripheral blood progenitor cells from 15 normal donors and 5 myelodysplastic patients, and on in vivo hemopoiesis in 30 patients with hypoplastic or myelodysplastic disorders. At concentrations similar to that reported as the plasma level after oral administration, danazol significantly increased CFU-GM colony growth in all normal donors, while the influence on CFU-E, BFU-E, CFU-MK and CFU-GEMM colony growth was less evident. The stimulatory effect on CFU-GM was observed even after accessory cell depletion. Np stimulatory effect either in vitro on the growth of all hemopoietic progenitors or in vivo was observed in 15 myelodysplastic patients, while 7 complete and 3 partial hematological responses occurred in 15 patients with hypoplastic disorders. In conclusion, our results suggest that danazol exerts a direct stimulatory activity in vitro at least on CFU-GM, and a hemopoietic stimulatory effect in vivo in hypoplastic but not in myelodysplastic disorders.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- Benefits of danazol treatment in patients with hemophilia A (classic hemophilia) via openalex
- Benefits of Danazol Treatment in Patients With Hemophilia A (Classic Hemophilia) via openalex
- Danazol Therapy for Autoimmune Hemolytic Anemia via openalex
- Danazol therapy in chronic immune thrombocytopenic purpura via openalex
- Effect of danazol on coagulation parameters and bleeding in hemophilia via openalex
- Effect of Danazol on Coagulation Parameters and Bleeding in Hemophilia via openalex
- Immunosuppressive effects of danazol in vitro via openalex
- Long-Term Danazol Therapy in Autoimmune Thrombocytopenia: Unmaintained Remission and Age-Dependent Response in Women via openalex
- Pituitary and Testicular Function Studies. I. Experience with a New Gonadal Inhibitor, 17α-Pregn-4-en-20-yno-(2,3-d) isoxazol-17-ol (Danazol)<sup>1</sup> via openalex
- Very Low Dose Danazol in Idiopathic Thrombocytopenic Purpura and its Role as an Immune Modulator via openalex
- doi:10.2307/3001968 via openalex
- doi:10.1111/j.1365-2141.1976.tb03563.x via openalex
- doi:10.1007/bf00320726 via openalex
- doi:10.1016/0090-1229(87)90016-x via openalex
- doi:10.1016/s0950-3536(89)80005-8 via openalex
- doi:10.1111/j.1365-2141.1982.tb08475.x via openalex
- doi:10.1056/nejm198306093082306 via openalex
- doi:10.1111/j.1365-2141.1985.tb04070.x via openalex
- doi:10.1182/blood.v43.3.351.351 via openalex
- doi:10.1159/000206176 via openalex
- doi:10.7326/0003-4819-103-1-58 via openalex
- doi:10.1182/blood.v48.6.855.855 via openalex
- doi:10.1182/blood.v52.6.1243.1243 via openalex
- doi:10.1172/jci108269 via openalex
- doi:10.1182/blood.v66.1.184.184 via openalex
- doi:10.1002/jcp.1040880202 via openalex
- doi:10.1002/jcp.1040880203 via openalex
Cited by (5)
- Development of hepatocellular carcinoma after long-term immunosuppressive therapy including danazol in a dog 2016
- Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome 2002
- Prolonged response to cyclosporin-A in hypoplastic refractory anemia and correlation with in vitro studies. 2000
- Identification and treatment of late onset Fanconi's anemia. 1996
- A review of 76 patients with myelodysplastic syndromes treated with danazol 1994
Source provenance
- openalex
- last seen: 2026-05-11T05:51:57.177246+00:00
License: CC0
· commercial use OK